<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/9195" -->
<rss version="0.92">
<channel>
	<title>Pyng Medical Corp</title>
	<link>http://www.pyng.com</link>
	<description>Saving lives by saving time through innovation in resuscitation&#174;</description>
	<lastBuildDate>Tue, 27 Jul 2010 22:57:28 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Pyng Medical to expand global distribution network to India</title>
		<description><![CDATA[Vancouver, B.C. – July 26, 2010– Pyng Medical Corp. (PYT: TSX .V) (the “Company” or “Pyng”) today announced it has expanded the network of global dealers to include India – Pyng Medical Corp., the world&#8217;s leading supplier of Sternal Intraosseous Infusion devices, announced expansion of its exclusive dealer network globally with a significant addition to [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-to-expand-global-distribution-network-to-india/</link>
			</item>
	<item>
		<title>Pyng Medical Corp. Announces SGS Certification</title>
		<description><![CDATA[Vancouver, BC  &#8211; July 22, 2010 &#8211; Pyng Medical Corp. (PYT: TSX .V) today announced it obtained recertification to ISO 13485:2003 standard and has certified to the new ISO 9001:2008 standard. Pyng Medical also retained their CE Mark for CRIC™ Cricothyrotomy System, FAST1® Intraosseous Infusion System and FASTx™ Sternal Intraosseous Device without any major [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-corp-announces-sgs-certification/</link>
			</item>
	<item>
		<title>Pyng Medical Reports Second Quarter 2010 Financial Results</title>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (PYT: TSX .V) today reported it’s financial and operating results for the three months ended March 31, 2010. All amounts are in Canadian dollars.
The total sales for this quarter were $1,578,715, an increase of 14% compared to $1,385,177 for the same period of last fiscal year, which resulted from the [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-reports-second-quarter-2010-financial-results/</link>
			</item>
	<item>
		<title>Pyng Receives Response from FDA Concerning CRIC™</title>
		<description><![CDATA[April 20th, 2010, Vancouver,  BC – Pyng Medical Corp. (PYT:  TSX .V) (the “Company” or “Pyng”) today announced that the United  States Food and Drug Administration (“FDA”) completed its review  of the Company’s 510(k) submission for its CRIC™  Kit Cricothyrotomy device. 
The Company pursued FDA approval to  market  [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-receives-response-from-fda-concerning-cric/</link>
			</item>
	<item>
		<title>Pyng Medical Receives Australian TGA Clearance</title>
		<description><![CDATA[FASTx™  Sternal Intraosseous Device and CRIC™  Kit Cricothyroidotomy Device
Vancouver, BC - Pyng Medical Corp.   (PYT: TSX .V) today announced the Company has received Australian TGA  clearance for its new and improved FASTx™  Sternal Intraosseous Device, as well as its new and innovative  CRIC™ Kit Cricothyroidotomy device, effective immediately.
The [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-receives-australian-tga-clearance/</link>
			</item>
	<item>
		<title>Pyng Medical Corp. Announces Election of Directors and Officers at 2010 Annual General Meeting and Issuance of Stock Options to a Director</title>
		<description><![CDATA[Vancouver, BC – Pyng Medical Corp. (the “Company”) (TSX-V: PYT) announced today that at the Annual General Meeting (“AGM”) of the shareholders held on March 9, 2010, the following persons were elected as directors: Robert (“Bob”) DiSilvio, Kevin O’Neill, Michael Jacobs, R.J. (“Bud”) Evans, Al Moloff and Edward A. (Ted) Bence.
At a Board Meeting held [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-corp-announces-election-of-directors-and-officers-at-2010-annual-general-meeting-and-issuance-of-stock-options-to-a-director/</link>
			</item>
	<item>
		<title>Pyng Medical Receives European CE Mark for FASTx™</title>
		<description><![CDATA[FASTx™ Intraosseous Infusion System Now Available in Europe
Vancouver, BC - Pyng Medical Corp. (PYT: TSX .V) today announced the Company has received European CE Mark regulatory clearance to market its new and improved FASTx™ Sternal Intraosseous Device, in Europe effective immediately.
The  FASTx™ Sternal Intraosseous Device is indicated for use in establishing a sternal intraosseous [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-receives-european-ce-mark-for-fastx%e2%84%a2/</link>
			</item>
	<item>
		<title>Pyng Medical Reports First Quarter 2010 Financial Results</title>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (PYT: TSX .V) today reported it’s financial and operating results for the three months ended December 31, 2009.  All amounts are in Canadian dollars.
The total sales for this quarter were $1,585,684, compared to $1,633,985 for the same period last fiscal year and the gross margin was $1,132,906, compared to [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-reports-first-quarter-2010-financial-results/</link>
			</item>
	<item>
		<title>Pyng Medical Corp. Opens U.S. Sales Office</title>
		<description><![CDATA[Vancouver, BC &#8211; Pyng Medical Corp. (PYT: TSX .V) (the “Company” or “Pyng”) announced today that it has opened its US sales office in Kirkland, Washington to service the growing demand for Pyng’s line of resuscitative care solutions in the United States. The Kirkland office expands the Company’s ability to offer sales and support services [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-corp-opens-u-s-sales-office/</link>
			</item>
	<item>
		<title>Pyng Medical Receives Health Canada License</title>
		<description><![CDATA[Vancouver, BC &#8211; Pyng Medical Corp. (PYT: TSX .V) today announced the Company has received Health Canada regulatory clearance to market its new and improved FASTx™ Sternal Intraosseous Device, effective immediately.
The FASTx™ Sternal Intraosseous Device is indicated for use in establishing a sternal intraosseous access route in adult and adolescent patients (12 years of age [...]]]></description>
		<link>http://www.pyng.com/news-releases/pyng-medical-receives-health-canada-license/</link>
			</item>
</channel>
</rss>
